Kane Biotech Announces Third Quarter 2022 Financial Results
November 24, 2022 16:10 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2022 financial results. ...
Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow
November 17, 2022 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Medela and MedPro Healthcare Sales Solutions Announce Partnership & Leadership to Drive Expansion in Wound Care Category
November 15, 2022 10:30 ET
|
Medela
McHenry, Ill., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Medela LLC announced today a new partnership with MedPro. The partnership will help expand access to Medela’s suite of wound therapy systems. This...
[Latest] Global Active Wound Care Market Size/Share Worth USD14190 Million by 2030 at a 5.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, Analysis, Outlook)
November 06, 2022 21:30 ET
|
Custom Market Insights
Sandy, Utah, USA, Nov. 06, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Active Wound Care Market Size, Trends and Insights By Type (Exudate Management,...
Kane Biotech Announces 510(k) Submission for its coactiv+™ Antimicrobial Hydrogel
November 03, 2022 07:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that it has recently submitted a 510(k) premarket...
Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall
October 18, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
October 13, 2022 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that the Company will be presenting at the Symposium...
Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall
October 11, 2022 06:45 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense
October 04, 2022 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has received an additional $425,000 USD of...
Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program
September 23, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...